Cargando…

Long-term testosterone replacement therapy reduces fatigue in men with hypogonadism

BACKGROUND: Testosterone replacement therapy (TRT) is one of the main lines of treatment for men with hypogonadism. This study sought to evaluate the influence of TRT in men with late-onset hypogonadism (LOH), regarding fatigue, coronary artery disease (CAD), carotid intima-media thickness (CIMT) an...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Almeida Ferreira, Maurício, Mendonça, José Alexandre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioExcel Publishing Ltd 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8823386/ https://www.ncbi.nlm.nih.gov/pubmed/35211178 http://dx.doi.org/10.7573/dic.2021-8-12

Ejemplares similares

Testosterone Replacement Therapy and Bone Mineral Density in Men with Hypogonadism
por: Kim, Se Hwa
Publicado: (2014)

Treatment of Men with Central Hypogonadism: Alternatives for Testosterone Replacement Therapy
por: Ide, Veerle, et al.
Publicado: (2020)

Outcomes of Prostate Biopsy in Men with Hypogonadism Prior or During Testosterone Replacement Therapy
por: Shoskes, Daniel A, et al.
Publicado: (2015)

ODP412 High Frequency of Erythrocytosis in Hypogonadal Men on Testosterone Replacement Therapy
por: Pérez-Luis, Jesús, et al.
Publicado: (2022)

OR25-06 The Effect of Testosterone Replacement Therapy on NAFLD in Elderly Hypogonadal Men
por: Seung Lee, Hae, et al.
Publicado: (2023)

Testosterone replacement in male hypogonadism
por: Kalra, Sanjay, et al.
Publicado: (2010)

Adverse events during testosterone replacement therapy in 95 young hypogonadal thalassemic men
por: Vincenzo, De Sanctis, et al.
Publicado: (2019)

Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study
por: Traish, A M, et al.
Publicado: (2014)

Testosterone Replacement Therapy in Hypogonadal Men and Myocardial Infarction Risk: Systematic Review & Meta-Analysis
por: Lee, Jun Hee, et al.
Publicado: (2021)

Efficacy of Testosterone Replacement Therapy in Correcting Anemia in Men With Hypogonadism: A Randomized Clinical Trial
por: Pencina, Karol M., et al.
Publicado: (2023)

Changes in left ventricular repolarization after short-term testosterone replacement therapy in hypogonadal males
por: Piccirillo, G., et al.
Publicado: (2019)

Adult-onset hypogonadism: evaluation and role of testosterone replacement therapy
por: Davidiuk, Andrew J., et al.
Publicado: (2016)

The Optimal Indication for Testosterone Replacement Therapy in Late Onset Hypogonadism
por: Shin, Yu Seob, et al.
Publicado: (2019)

Long-term Opioids Linked to Hypogonadism and the Role of Testosterone Supplementation Therapy
por: Marudhai, Suganya, et al.
Publicado: (2020)

Testosterone replacement therapy improves the health-related quality of life of men diagnosed with late-onset hypogonadism
por: Almehmadi, Yousef, et al.
Publicado: (2016)

Testosterone replacement in hypogonadal men alters the HDL proteome but not HDL cholesterol efflux capacity
por: Rubinow, Katya B., et al.
Publicado: (2012)

Efficacy and safety of testosterone replacement therapy in men with hypogonadism: A meta-analysis study of placebo-controlled trials
por: GUO, CHANGCHENG, et al.
Publicado: (2016)

The Effect of Testosterone Replacement Therapy on Penile Hemodynamics in Hypogonadal Men With Erectile Dysfunction, Having Veno-Occlusive Dysfunction
por: Efesoy, Ozan, et al.
Publicado: (2018)

Testosterone replacement therapy in insulin‐sensitive hypogonadal men restores phosphatidylcholine levels by regulation of arachidonic acid metabolism
por: Fanelli, Giuseppina, et al.
Publicado: (2020)

Predictive factors for efficacy of testosterone replacement therapy for late-onset hypogonadism in Japanese men: a preliminary report
por: Kondoh, Nobuyuki, et al.
Publicado: (2023)

The impact of long-term Testosterone Therapy (TTh) in renal function (RF) among hypogonadal men: An observational cohort study
por: Alwani, Mustafa, et al.
Publicado: (2021)

Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study)
por: Jones, T. Hugh, et al.
Publicado: (2011)

Hypogonadism in the Aging Male Diagnosis, Potential Benefits, and Risks of Testosterone Replacement Therapy
por: Surampudi, Prasanth N., et al.
Publicado: (2012)

SUN-LB114 Remission of Type 2 Diabetes (DMT2) in Hypogonadal Men Under Long-Term Testosterone Therapy
por: Mskhalaya, George, et al.
Publicado: (2020)

Testosterone therapy in hypogonadal men results in sustained and clinically meaningful weight loss
por: Yassin, AA, et al.
Publicado: (2013)

Testosterone therapy in hypogonadal men: a systematic review and network meta-analysis
por: Elliott, Jesse, et al.
Publicado: (2017)

Testosterone therapy and bone quality in men with diabetes and hypogonadism: Study design and protocol
por: Russo, Vittoria, et al.
Publicado: (2021)

Voiding function improves under long-term testosterone treatment (TTh) in hypogonadal men, independent of prostate size
por: Yassin, Aksam, et al.
Publicado: (2023)

Cognitive effects of testosterone and finasteride administration in older hypogonadal men
por: Borst, Stephen E, et al.
Publicado: (2014)

Testosterone versus clomiphene citrate in managing symptoms of hypogonadism in men
por: Dadhich, Pranav, et al.
Publicado: (2017)

PMON260 Cost-Effectiveness of Testosterone Treatment for Men with Hypogonadism
por: Jayasena, Channa, et al.
Publicado: (2022)

Testosterone replacement therapy for older men
por: Borst, Stephen E, et al.
Publicado: (2007)

Risks of testosterone replacement therapy in men
por: Osterberg, E. Charles, et al.
Publicado: (2014)

Transdermal testosterone replacement therapy in men
por: Ullah, M Iftekhar, et al.
Publicado: (2014)

Hypogonadism and testosterone replacement therapy in end-stage renal disease (ESRD) and transplant patients
por: Snyder, Grace, et al.
Publicado: (2016)

Plasma Metabolomics Profile of “Insulin Sensitive” Male Hypogonadism after Testosterone Replacement Therapy
por: Zolla, Lello, et al.
Publicado: (2022)

Who are the fair candidates for testosterone replacement therapy in patients with late-onset hypogonadism symptoms?
por: Amano, Toshiyasu
Publicado: (2023)

The complex relation between obstructive sleep apnoea syndrome, hypogonadism and testosterone replacement therapy
por: Graziani, Andrea, et al.
Publicado: (2023)

Remission of type 2 diabetes in a hypogonadal man under long-term testosterone therapy
por: Haider, Ahmad, et al.
Publicado: (2017)

AB098. Can concomitant dutasteride reduce the effect of testosterone replacement therapy in men with late-onset hypogonadism? A 24-week, randomized, parallel study
por: Park, Hyun Jun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_akb3d85e7vfjnq3othtdhs93tb